$KRSA
Korsana Biosciences, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Waltham, MA
KRSA chart
What traders are saying about $KRSA
Latest postsKorsana Biosciences, Inc. news
- Cyclerion Therapeutics (NASDAQ:KRSA) Stock Falls 6.4% - Here's What Happened
MarketBeat ·
- Can Tenet Healthcare Beat Q3 Earnings on Ambulatory Care Strength?
Yahoo Finance ·
- Korsana Biosciences (KRSA) Stock Price, News & Analysis
Stock Titan ·
- Form 144 KORSANA BIOSCIENCES For: 22 October By Investing.com
Investing.com Nigeria ·
- Korsana Biosciences (KRSA) At $31.20 Leaves Valuation Questions On A Sharp 2026 Run
Yahoo Finance ·
- Korsana Biosciences Completes Closing of Merger with Cyclerion Therapeutics and Previously Announced Private Placement of $380 Million
Yahoo Finance ·
Korsana Biosciences, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $2.1M | $2.0M | $0 | $297,000 |
| Net income | -$3.5M | -$3.1M | -$5.3M | -$44.1M |
| Diluted EPS | $-1.11 | $-1.21 | $-2.25 | $-20.28 |
| Total assets (year end) | $10.0M | $9.6M | $13.4M | $18.1M |
| Cash and equivalents (year end) | $3.2M | $3.2M | $7.6M | $13.4M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Korsana Biosciences, Inc.
- Ticker
- KRSA (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Waltham, MA
- Incorporated in
- MA
- Fiscal year end
- December 31
- SEC CIK
- 1755237
- Former names
- Cyclerion Therapeutics, Inc.
Frequently asked questions
What exchange is Korsana Biosciences, Inc. listed on?
Korsana Biosciences, Inc. trades on the Nasdaq under the ticker symbol KRSA.
What industry is Korsana Biosciences, Inc. in?
Korsana Biosciences, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Korsana Biosciences, Inc. headquartered?
Korsana Biosciences, Inc.'s business address on file with the SEC is in Waltham, MA.
When does Korsana Biosciences, Inc.'s fiscal year end?
Korsana Biosciences, Inc.'s fiscal year ends on December 31.
How much revenue did Korsana Biosciences, Inc. report?
Korsana Biosciences, Inc. reported $2.1M in revenue for calendar year 2025, according to its SEC filings.